An Open-Label Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
收藏DataCite Commons2025-05-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003085/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study evaluated the quality of life (QOL) and economic impact of adalimumab treatment in participants with ulcerative colitis (UC).
提供机构：
Vivli
创建时间：
2018-10-27
